JP2017510400A5 - - Google Patents

Download PDF

Info

Publication number
JP2017510400A5
JP2017510400A5 JP2016575315A JP2016575315A JP2017510400A5 JP 2017510400 A5 JP2017510400 A5 JP 2017510400A5 JP 2016575315 A JP2016575315 A JP 2016575315A JP 2016575315 A JP2016575315 A JP 2016575315A JP 2017510400 A5 JP2017510400 A5 JP 2017510400A5
Authority
JP
Japan
Prior art keywords
item
composition
self
solution
assembling peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016575315A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017510400A (ja
JP6554121B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/019740 external-priority patent/WO2015138475A1/en
Publication of JP2017510400A publication Critical patent/JP2017510400A/ja
Publication of JP2017510400A5 publication Critical patent/JP2017510400A5/ja
Application granted granted Critical
Publication of JP6554121B2 publication Critical patent/JP6554121B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016575315A 2014-03-10 2015-03-10 気管支閉鎖剤としての自己組織化ペプチド Expired - Fee Related JP6554121B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201461950529P 2014-03-10 2014-03-10
US61/950,529 2014-03-10
US201461953146P 2014-03-14 2014-03-14
US61/953,146 2014-03-14
PCT/US2015/019740 WO2015138475A1 (en) 2014-03-10 2015-03-10 Self-assembling peptides as bronchial obstruction agents

Publications (3)

Publication Number Publication Date
JP2017510400A JP2017510400A (ja) 2017-04-13
JP2017510400A5 true JP2017510400A5 (https=) 2018-05-31
JP6554121B2 JP6554121B2 (ja) 2019-07-31

Family

ID=52737414

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016575315A Expired - Fee Related JP6554121B2 (ja) 2014-03-10 2015-03-10 気管支閉鎖剤としての自己組織化ペプチド

Country Status (5)

Country Link
US (2) US20170173221A1 (https=)
EP (1) EP3116523B1 (https=)
JP (1) JP6554121B2 (https=)
ES (1) ES2706492T3 (https=)
WO (1) WO2015138475A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2011118341A (ru) 2008-10-06 2012-11-20 3-Д Матрикс, Лтд. (Jp) Агент для окклюзии тканей
WO2014008400A2 (en) 2012-07-06 2014-01-09 3-D Matrix, Inc. Fill-finish process for peptide solutions
BR112016019510A2 (pt) 2014-03-10 2017-10-24 3 D Matrix Ltd esterilização e filtração de composições de peptídeos
RU2016139369A (ru) * 2014-03-10 2018-04-10 3-Д Матрикс, Лтд. Композиции самоорганизующихся пептидов
US10245299B2 (en) 2014-03-10 2019-04-02 3-D Matrix, Ltd. Autoassembling peptides for the treatment of pulmonary bulla
US10814038B2 (en) 2016-01-06 2020-10-27 3-D Matrix, Ltd. Combination compositions
JP2021506815A (ja) 2017-12-15 2021-02-22 株式会社スリー・ディー・マトリックス 界面活性ペプチドナノ構造および薬物送達における使用
EP3818071A2 (en) * 2018-07-03 2021-05-12 3-D Matrix, Ltd. Ionic self-assembling peptides
CN115397454A (zh) 2020-03-31 2022-11-25 立美基股份有限公司 通过辐照对自组装肽进行灭菌
US20250281676A1 (en) * 2020-08-10 2025-09-11 Gel4Med, Inc. Delivery of cells and tissues with self-assembling peptide hydrogel materials
CN116390691A (zh) * 2020-08-10 2023-07-04 歌尔4梅德股份有限公司 自组装的两亲性肽水凝胶
CN116347980A (zh) * 2020-08-10 2023-06-27 歌尔4梅德股份有限公司 自组装的两亲性肽水凝胶的局部和肠外使用和施用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004508140A (ja) * 2000-09-11 2004-03-18 クロージャー　メディカル　コーポレイション 気管支閉塞法および装置
AU2003249606A1 (en) * 2002-05-13 2003-12-02 Massachusetts Institute Of Technology Angiogenesis and cardiac tissue engineering with peptide hydrogels and related compositions and methods of use thereof
ES2673947T3 (es) * 2006-04-25 2018-06-26 Massachusetts Institute Of Technology Composiciones y métodos para afectar al movimiento de contaminantes, líquidos corporales u otras entidades y/o afectar a otras condiciones fisiológicas
RU2011118341A (ru) * 2008-10-06 2012-11-20 3-Д Матрикс, Лтд. (Jp) Агент для окклюзии тканей
JP6034868B2 (ja) * 2011-09-02 2016-11-30 株式会社スリー・ディー・マトリックス 胸部の空気漏れ閉塞のための両親媒性ペプチド
US10245299B2 (en) * 2014-03-10 2019-04-02 3-D Matrix, Ltd. Autoassembling peptides for the treatment of pulmonary bulla

Similar Documents

Publication Publication Date Title
JP2017510400A5 (https=)
JP2017513928A5 (https=)
JP2017513927A5 (https=)
US10952961B2 (en) Implants and constructs including hollow fibers
JP6554121B2 (ja) 気管支閉鎖剤としての自己組織化ペプチド
JP5681276B2 (ja) 肺高血圧症のための治療
Machiels et al. Endoscopy/EUS-guided fiducial marker placement in patients with esophageal cancer: a comparative analysis of 3 types of markers
ES2762250T5 (es) Tratamiento combinado del cáncer
JP2019528320A5 (https=)
JP2013501224A5 (https=)
JP2022008403A5 (https=)
JP2016515113A5 (https=)
KR20110081204A (ko) 트레프로스티닐의 폐 심부 전달
RU2018136580A (ru) Цитратная соль (s)-4-((s)-3-фтор-3-(2-(5,6,7,8-тетрагидро-1,8-нафтиридин-2-ил)этил)пирролидин-1-ил)-3-(3-(2-метоксиэтокси)фенил)бутановой кислоты
JP2025515491A5 (https=)
KR101835895B1 (ko) 목시플록사신을 귀에 도포하기 위한 방법 및 조성물
ES2774773T3 (es) Agente terapéutico para la osteoporosis
RU2020109705A (ru) Соединения и их фармацевтические композиции для применения в лечении фиброзных заболеваний
JP2019531308A5 (https=)
JP2019518569A5 (https=)
Guevara et al. Porcupine quill migration in the thoracic cavity of a German shorthaired pointer
Ursella et al. The use of non-invasive ventilation in the treatment of acute cardiogenic pulmonary edema.
ES2661173T3 (es) Combinación de solución de aminoácidos y un derivado de gelatina para inhibir la absorción renal
JP7090941B2 (ja) 吸入粉末剤、その評価方法及びその用途
JP2010506855A5 (https=)